» Articles » PMID: 25062013

Granulocyte-colony Stimulating Factor Attenuates Oligomeric Amyloid β Neurotoxicity by Activation of Neprilysin

Overview
Journal PLoS One
Date 2014 Jul 26
PMID 25062013
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Soluble oligomeric amyloid β (oAβ) causes synaptic dysfunction and neuronal cell death, which are involved in the pathogenesis of Alzheimer's disease (AD). The hematopoietic growth factor granulocyte-colony stimulating factor (G-CSF) is expressed in the central nervous system (CNS) and drives neurogenesis. Here we show that G-CSF attenuated oAβ neurotoxicity through the enhancement of the enzymatic activity of Aβ-degrading enzyme neprilysin (NEP) in neurons, while the NEP inhibitor thiorphan abolished the neuroprotection. Inhibition of MEK5/ERK5, a major downstream effector of G-CSF signaling, also ablated neuroprotective effect of G-CSF. Furthermore, intracerebroventricular administration of G-CSF enhanced NEP enzymatic activity and clearance of Aβ in APP/PS1 transgenic mice. Thus, we propose that G-CSF may be a possible therapeutic strategy against AD.

Citing Articles

Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Nehra G, Bauer B, Hartz A Pharmacol Ther. 2022; 234:108119.

PMID: 35108575 PMC: 9107516. DOI: 10.1016/j.pharmthera.2022.108119.


Colony stimulating factors in the nervous system.

Chitu V, Biundo F, Stanley E Semin Immunol. 2021; 54:101511.

PMID: 34743926 PMC: 8671346. DOI: 10.1016/j.smim.2021.101511.


Neuroprotection through G-CSF: recent advances and future viewpoints.

Rahi V, Jamwal S, Kumar P Pharmacol Rep. 2021; 73(2):372-385.

PMID: 33389706 DOI: 10.1007/s43440-020-00201-3.


Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Xin S, Tan L, Cao X, Yu J, Tan L Neurotox Res. 2018; 34(3):733-748.

PMID: 29626319 DOI: 10.1007/s12640-018-9895-1.


Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET.

Barron A, Tokunaga M, Zhang M, Ji B, Suhara T, Higuchi M J Neuroinflammation. 2016; 13(1):221.

PMID: 27578213 PMC: 5006247. DOI: 10.1186/s12974-016-0700-x.

References
1.
Avalos B . Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 1996; 88(3):761-77. View

2.
Iwata N, Tsubuki S, Takaki Y, SHIROTANI K, Lu B, Gerard N . Metabolic regulation of brain Abeta by neprilysin. Science. 2001; 292(5521):1550-2. DOI: 10.1126/science.1059946. View

3.
Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R . The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005; 115(8):2083-98. PMC: 1172228. DOI: 10.1172/JCI23559. View

4.
Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T . Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience. 2009; 163(1):55-72. PMC: 5966834. DOI: 10.1016/j.neuroscience.2009.05.071. View

5.
Busciglio J, Yankner B . Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995; 378(6559):776-9. DOI: 10.1038/378776a0. View